01Jul
Novartis and Alcon FCPA Enforcement Action: Lessons Learned (Part III of III)
At the outset, Novartis is “lucky” – the settlement is relatively positive, despite its 2016 SEC enforcement action in China. Given Novartis weak culture of compliance (if anything, a better description may be a culture of non-compliance) and its status as a recidivist, Novartis could have been slammed with a stiffer enforcement action, including assignment of an independent corporate compliance monitor and a higher penalty. ...
By:
Michael Volkov
Related
The first cuts from WeWork hit this week, and they’ll take the form of 2,400 employees around the w...
Read More >
With some Canada Labour Code (CLC) amendments in Bill C-44, the Budget Implementation Act, 2017, No....
Read More >
The Colorado Department of Labor and Employment’s Division of Labor Standards and Statistics has re...
Read More >
As the summer begins to wind down, the first whispers of fall rippling through cool evening breezes ...
Read More >
Activism affects virtually everyone now—even those who may never have to deal with an activist - I...
Read More >
In Project Surveillance, Inc. v. The Travelers Indemnity Company, No. 4:19-CV-03324, 2020 WL 292247 ...
Read More >